Samarth Kulkarni sold $469K of CRISPR Therapeutics AG (CRSP)

Executed Mar 23, disclosed Mar 24, 1 day later.

Value, as filed

$469K

10,020 sh × $46.78

Executed

Mar 23

the trade date, as filed

Disclosed

Mar 24

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Samarth Kulkarni Chief Executive Officer profile →

Samarth Kulkarni (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $5.2M of CRSP (90,000 sh across 3 lots, as filed), executed Jan 20.

The name

CRSP

CRISPR Therapeutics AG CRSP · Healthcare · 39 filings in 24 months ticker →

Healthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Samarth Kulkarni in CRSP

CRSPSALE CRISPR Therapeutics AG $2.4M
47,837 sh × $49.78
Exec Oct 19
Filed Oct 20 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG $202K
4,098 sh × $49.26
Exec Oct 14
Filed Oct 15 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG $499K
10,349 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $517K
9,798 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $366K
6,967 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $5.2M
90,000 sh across 3 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $3.5M
50,895 sh × $67.91
Exec Oct 17 2025
Filed Oct 20 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $283K
4,242 sh × $66.60
Exec Oct 14 2025
Filed Oct 15 2025 · 5:30 PM ET